ArticleOncology letters2013

Synergistic interaction between sorafenib and gemcitabine in EGFR-TKI-sensitive and EGFR-TKI-resistant human lung cancer cell lines.

Jing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.